OSR Health says Nasdaq has not approved or endorsed shareholder loyalty CVR program

PUBT · 1d ago
OSR Health says Nasdaq has not approved or endorsed shareholder loyalty CVR program
  • OSR Holdings corrected a July 31 statement that implied Nasdaq had approved or endorsed its Shareholder Loyalty CVR Program.
  • Nasdaq’s communication was described as a preliminary verbal view limited to whether the program would trigger a mechanical ex-date price adjustment.
  • Outside that technical point, Nasdaq has not given a definitive opinion on the program.
  • The August 14, 2026 record date for the Shareholder Loyalty CVR Program remains unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608071500ACCESSWRNAPR_____1204559) on August 07, 2026, and is solely responsible for the information contained therein.